The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular Health
EPOCH
1 other identifier
observational
300
1 country
1
Brief Summary
The purpose of this study is to investigate whether exposure to hypertensive disorders of pregnancy and/or a preterm birth results in alterations in the cardiovascular system during infancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 13, 2013
CompletedFirst Posted
Study publicly available on registry
June 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedMay 25, 2016
May 1, 2016
6.1 years
June 13, 2013
May 23, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Systolic Cardiac Function
Cardiac Function will be assessed by ECHO at birth and 3 months
Birth and 3 months
Secondary Outcomes (6)
Micro-vascular Structure
Birth and 3 months
Pulse wave velocity and pulse-wave analysis
Birth and 3 months
Cardiac Structure
Birth and 3 months
Cardiac diastolic function
Birth and 3 months
Blood pressure
Birth and 3 months
- +1 more secondary outcomes
Study Arms (5)
Normotensive Term
Infants born at term (\>37 weeks) to Normotensive pregnancies
Term Preeclampsia
Infants born at term (\>37 weeks gestation) and exposed to a preeclamptic pregnancy
Preterm Normotensive
Infants born to Normotensive pregnancies at \<37 weeks gestation
Preterm Hypertensive
Infants born to hypertensive pregnancies at \<37 weeks completed gestation
Term Pregnancy-induced Hypertension
Infants born at term (\>37 weeks gestation) and exposed to pregnancy-induced hypertension
Eligibility Criteria
Study population is drawn from infants admitted to or delivered in the OUH NHS Foundation trust to normotensive or hypertensive pregnancies across a range of gestations. The mothers of these infants form a secondary study cohort.
You may qualify if:
- Available for assessment within the neonatal period,
- Parent is willing and able to give informed consent for participation in the study,
- Physical condition is suitable to allow non-invasive vascular testing,
- Cases: Diagnosed during pregnancy with preeclampsia or gestational hypertension and/or delivered preterm (\<37 weeks gestation)
- Controls: No history of gestational hypertension or preeclampsia during this pregnancy and delivered at term (\>37 weeks gestation)
You may not qualify if:
- Parent is unwilling to give consent,
- Unavailable for assessment of cardiovascular system,
- Physical condition unsuitable to allow for non-invasive testing of cardiovascular system,
- Evidence of congenital cardiovascular disease (with the exception of Persistent Patent Ductus Arterious (PDA) and Atrial Septal Defect (ASD)),
- Cardiorespiratory instability at time of proposed measures,
- Active infection at time of proposed study measures,
- Mother of infant is excluded from the study. (Aged \<16 years, unable or unwilling to consent to study or Physical condition post delivery such that it would preclude participation in the study)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- British Heart Foundationcollaborator
Study Sites (1)
Cardiovascular Clinical Research Facility, Dept of Cardiovascular Medicine, University of Oxford
Oxford, Oxfordshire, OX3 9DU, United Kingdom
Biospecimen
Whole blood, serum, plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Leeson, PhD, FRCP
University of Oxford Department of Cardiovascular Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2013
First Posted
June 28, 2013
Study Start
August 1, 2011
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
May 25, 2016
Record last verified: 2016-05